US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class III · Low risk Terminated

Dr. Reddys

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. D-0382-2022
Class III · Low risk Terminated

Kroger

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 30142-611-14 D-0381-2022
Class III · Low risk Terminated

Rite Aid Pharmacy

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. D-0380-2022
Class III · Low risk Terminated

Rugby

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 0536-1242-07 D-0379-2022
Class III · Low risk Terminated

Wal-Fex D

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 0363-1606-20 D-0378-2022
Class II · Moderate risk Terminated

Metoprolol Tartrate Tablets

Reason Complaint received of foreign matter (metal) embedded in tablet.

Rubicon Research Private Limited NDC 52817-360-00 D-0362-2022
Class II · Moderate risk Terminated

Metformin 750 mg Extended Release NDC # 70518-2920-00

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

RemedyRepack Inc. NDC 70518-2920-00 D-0366-2022
Class II · Moderate risk Terminated

Pioglitazone Tablets USP

Reason Superpotent and Failed Tablet/Capsule Specifications

Aurobindo Pharma USA Inc. NDC 57237-221-05 D-0450-2022
Class II · Moderate risk Terminated

Cefixime 400 mg capsule

Reason Failed Impurities/Degradation Specifications

RemedyRepack Inc. NDC 70518-2749-02 D-0360-2022
Class III · Low risk Terminated

Oxycodone Hydrochloride Tablets

Reason Out-of-specification impurity test result observed at 18-month long term stability time point.

Lupin Pharmaceuticals Inc. NDC 43386-432-01 D-0358-2022
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Viona Pharmaceuticals INC NDC 72578-036-01 D-0392-2022
Class II · Moderate risk Terminated

Nitroglycerin Lingual Spray

Reason Defective Delivery System

Padagis US LLC NDC 45802-210-02 D-0372-2022
Class III · Low risk Terminated

Gatifloxacin Ophthalmic Solution

Reason Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class II · Moderate risk Ongoing

Medroxyprogesterone Acetate Injection

Reason Lack of Assurance of Sterility

Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy D-0463-2022
Class I · High risk Terminated

SENNA Syrup

Reason Microbial Contamination of Non-Sterile Product

Lohxa, LLC NDC 50262-731-24 D-0377-2022
Class II · Moderate risk Terminated

Cefixime Capsules

Reason Failed impurities/degradation specifications

Ascend Laboratories, LLC NDC 67877-584-50 D-0359-2022
Class I · High risk Terminated

Clobetasol Propionate Ointment USP

Reason Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1259-3 D-0375-2022
Class II · Moderate risk Terminated

Brinzolamide Ophthalmic Suspension

Reason Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.

Teva Pharmaceuticals USA NDC 0591-2127-79 D-0373-2022
Class II · Moderate risk Terminated

Trypan Blue 0.03%

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1348-01 D-0449-2022